Skip to main content

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Meds A-Z

Meloxicam

Detailed information about Meloxicam

Official label facts Owner quick guide first Marketing clearly labeled
Talk to a Vet / Find a Vet Near You Start Symptom Intake
Showing simplified owner view. Switch to Vet View for full technical detail.

Pet Owner Quick Guide

Start here: what this medicine is for, what it does, and when it's usually needed.

Usually used for:

For the control of pain and inflammation associated with osteoarthritis in dogs.

What it does:

For the control of pain and inflammation associated with osteoarthritis. For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered pri...

When it's needed:

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. F...

Call your vet sooner if you notice:

  • Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Commonly reported reactions:

  • (2 reports)
  • (2 reports)
  • (2 reports)

What to ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Talk to a Vet / Find a Vet Near You
Image coming soon
Meloxicam

Meloxicam

Drug type: Generic ingredient • Branded profile • FDA branded products available

Species: Both

Manufacturer: MSK

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: MSK
Form: Injectable Solution, Liquid (Solution), Liquid (Suspension), Oral Suspension, Solution For Injection, Sterile Solution
Identifiers:
ANADA: 200485 ANADA: 200491 ANADA: 200497 ANADA: 200540 ANADA: 200550 ANADA: 200727 ANADA: 200794 ANADA: 200816 ANADA: 200817 NADA: 141213 NADA: 141219 NADA: 141346 NDC Package: 0010-6013-01 NDC Package: 0010-6014-01 NDC Package: 0010-6014-02 NDC Package: 0010-6015-01 NDC Package: 0010-6015-02 NDC Package: 0010-6015-03 NDC Package: 0010-6015-04 NDC Package: 11695-6936-1
Source metadata:

Warnings / Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
29
Species represented
2
Most Reported Reactions
Reaction Cases Species Serious cases
2 Cat, Dog 2
2 Cat, Dog 2
2 Cat, Dog 2
1 Cat 1
1 Cat 1
1 Dog 1
1 Cat 1
1 Cat 1

Species coverage: Cat (21) Dog (11)

View detailed reaction table
Reaction Species Seriousness Frequency Reports
Dog Serious - 1
Dog Serious - 1
Cat Serious - 1
Cat Serious - 1
Cat Serious - 1
Dog Serious - 1
Cat Serious - 1
Cat Serious - 1
Dog Serious - 1
Cat Serious - 1
Cat Serious - 1
Cat Serious - 1
Cat Serious - 1
Dog Serious - 1
Cat Serious - 1
Cat Serious - 1
Cat Serious - 1
Dog Non-serious - 1
Cat Serious - 1
Dog Serious - 1
Cat Serious - 1
Dog Non-serious - 1
Cat Serious - 1
Cat Non-serious - 1
Dog Serious - 1
Cat Serious - 1
Cat Serious - 1
Dog Serious - 1
Cat Serious - 1
Dog Serious - 1
Cat Serious - 1
Cat Serious - 1
Source metadata:

Storage & Handling

No storage/handling guidance is linked yet.

Source metadata: No source yet.

Documents

Official label facts are separated from secondary summaries.

Official documents: 41 • Secondary summaries: 0

Official label facts
Secondary summaries

No source yet.

Source metadata:

Promotional Materials (Marketing)

This content is marketing material and not clinical guidance.

No marketing assets are linked yet.

No source yet.

Source metadata: No source yet.
Talk to a Vet / Find a Vet Near You
Technical appendix (vet reference)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Feb 16, 2026, 11:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Feb 16, 2026, 11:00 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:02 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 12, 2026, 10:42 PM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Loxicom® Meloxicam Meloxicam Injection Meloxicam Oral Suspension Meloxicam Solution for Injection Meloxidyl® Meloxisol™ Metacam® 5 mg/mL Solution for Injection Metacam® Oral Suspension OroCAM® Transmucosal Oral Spray
Case-reported brands (openFDA): MSK
Catalog species: Both • FDA-labeled species: Cat, Dog
Rx/OTC: RX
Form/route: Injectable Solution, Liquid (Solution), Liquid (Suspension), Oral Suspension, Solution For Injection, Sterile Solution, Transmucosal Oral Spray • Intravenous, Oral, Subcutaneous
Applications: ANADA 200-794 • ANADA 200-817 • ANADA 200-816 • ANADA 200-727 • NADA 141-219 • NADA 141-213 • ANADA 200-485 • ANADA 200-491 • ANADA 200-540 • ANADA 200-497 • ANADA 200-550 • NADA 141-346
NDC: Packages 11695-6936-1 11695-6936-2 11695-7008-1 11695-7008-2 55529-680-32 55529-680-33 • Products 11695 11695 11695 11695 55529 55529
Documents: 29 (FOI: 14) • SPL: 12 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 56 • Cat 56 • View
Case summaries: 11 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Explore
Linked using: Fda_Label (0.95), Fda_Label (0.95), Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: M19.90
Unspecified osteoarthritis, unspecified site

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Top reaction signals
Abdominal pain (1) Abnormal radiograph finding (1) Adipsia (1) Anaemia NOS (1) Anorexia (1) Anorexia (1) Crust (1) Death (1) Death (1) Decreased appetite (1) Decreased blood urea nitrogen (BUN) or creatinine (1) Dehydration (1) Desquamation (1) Diarrhoea (1) Dysphoria (1) Elevated renal parameters (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200485 ANADA: 200491 ANADA: 200497 ANADA: 200540 ANADA: 200550 ANADA: 200727 ANADA: 200794 ANADA: 200816 ANADA: 200817 NADA: 141213 NADA: 141219 NADA: 141346 NDC Package: 0010-6013-01 NDC Package: 0010-6014-01 NDC Package: 0010-6014-02 NDC Package: 0010-6015-01 NDC Package: 0010-6015-02 NDC Package: 0010-6015-03 NDC Package: 0010-6015-04 NDC Package: 11695-6936-1 NDC Package: 11695-6936-2 NDC Package: 11695-6966-1 NDC Package: 11695-6966-2 NDC Package: 11695-6966-3
Package NDC Product NDC Form / Route Status
0010-6013-01 0010 -
0010-6014-01 0010 -
0010-6014-02 0010 -
0010-6015-01 0010 -
0010-6015-02 0010 -
0010-6015-03 0010 -
0010-6015-04 0010 -
11695-6936-1 11695 -
11695-6936-2 11695 -
11695-6966-1 11695 -
11695-6966-2 11695 -
11695-6966-3 11695 -
11695-6966-4 11695 -
11695-7008-1 11695 -
11695-7008-2 11695 -
13744-505-01 13744 -
13744-505-10 13744 -
13744-505-20 13744 -
13744-505-32 13744 -
13985-559-10 13985 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

Data Sources & Revision History

Every non-trivial field is expected to include provenance and update timestamps.

Official 32 Clinical 0 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and de… (Official, 2026-02-12)
  • side_effects: Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in 'Neurological'), Anorexia, Death by euthanasia, … (Official, 2026-02-12)
  • usage: For the control of pain and inflammation associated with osteoarthritis. For the control of postoperative pain and inflammation associated with orthopedic surg… (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Meloxisol™
RX
Meloxicam
Oral Suspension • Oral
Label highlights
Official documents
Cronus Pharma Specialities India Private Ltd. ANADA 200-794 Approved Aug 28, 2025
Meloxicam Oral Suspension
RX
Meloxicam
Oral Suspension • Oral
Label highlights
Official documents
Felix Pharmaceuticals Pvt. Ltd. ANADA 200-817 Approved Jul 31, 2025
Meloxisol™
RX
Meloxicam
Oral Suspension • Oral
Label highlights
Official documents
Cronus Pharma Specialities India Private Ltd. ANADA 200-816 Approved Jul 31, 2025
Meloxicam
RX
Meloxicam
Injectable Solution • Intravenous, Subcutaneous
Label highlights
Official documents
Felix Pharmaceuticals Pvt. Ltd. ANADA 200-727 Approved Nov 7, 2024
Metacam® 5 mg/mL Solution for Injection
RX
Meloxicam
Liquid (Solution) • Subcutaneous, Intravenous
Label highlights
Official documents
Boehringer lngelheim Animal Health USA, Inc. NADA 141-219 Approved Mar 1, 2024
Metacam® Oral Suspension
RX
Meloxicam
Liquid (Suspension) • Oral
Label highlights
Official documents
Boehringer lngelheim Animal Health USA, Inc. NADA 141-213 Approved Dec 21, 2023
Meloxicam Injection
RX
Meloxicam
Sterile Solution • Subcutaneous, Intravenous
Label highlights
Official documents
Accord Healthcare, Inc. ANADA 200-485 Approved Jan 31, 2023
Loxicom®
RX
Meloxicam
Solution For Injection • Intravenous, Subcutaneous
Label highlights
Official documents
Norbrook Laboratories, Ltd. ANADA 200-491 Approved Aug 2, 2021
Meloxicam Solution for Injection
RX
Meloxicam
Sterile Solution • Intravenous, Subcutaneous
Label highlights
Official documents
Dechra Veterinary Products LLC ANADA 200-540 Approved Aug 18, 2020
Loxicom®
RX
Meloxicam
Oral Suspension • Oral
Label highlights
Official documents
Norbrook Laboratories, Ltd. ANADA 200-497 Approved Feb 27, 2019
Meloxidyl®
RX
Meloxicam
Oral Suspension • Oral
Label highlights
Official documents
Ceva Sante Animale ANADA 200-550 Approved Dec 21, 2018
OroCAM® Transmucosal Oral Spray
RX
Meloxicam
Transmucosal Oral Spray • Oral
Label highlights
Official documents
Zoetis Inc. NADA 141-346 Approved Nov 13, 2017

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Composition / specifications
Each milliliter of suspension contains 0.5 milligrams (mg) meloxicam
Dogs
Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.

Limitations

FDA page: Open in Animal Drugs @ FDA

Dogs
Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.

Limitations

FDA page: Open in Animal Drugs @ FDA

Composition / specifications
1.5 mg/mL
Dogs
Indication

For the control of pain and inflammation associated with osteoarthritis in dogs.

Dosage

Administer orally as a single dose at 0.09 mg per pound (mg/lb) body weight (0.2 mg per kilogram (mg/kg)) on the first day of treatment. For all treatments after day 1, administer 0.045 mg/lb (0.1 mg/kg) body weight once daily.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
5 mg/mL
Dogs
Indication

For the control of pain and inflammation associated with osteoarthritis.

Dosage

Meloxicam injection should be administered initially as a single dose, at0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.

Limitations
Cats
Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

Dosage

Administer a single, one-time subcutaneous dose of Meloxicam injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated. To ensure accuracy of dosing, the use of a 1 mL graduated syringe is recommended.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 5.0 milligrams (mg) meloxicam.
Cats
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery.
Dosage
Administer 0.14 mg/lb (0.3 milligram per kilogram) body weight as a single, one-time subcutaneous injection.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer 0.09 mg per pound (0.2 milligram per kilogram) body weight by intravenous or subcutaneous injection on the first day of treatment. For treatment after day 1, administer meloxicam suspension orally at 0.045 mg/lb (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of suspension contains 0.5 or 1.5 milligrams (mg) meloxicam.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer orally as a single dose at 0.09 mg per pound body weight (0.2 milligram per kilogram) on the first day of treatment. For all treatment after day 1, administer 0.045 milligram per pound (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis.
Dosage

Administer initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth.

Limitations
Cats
Indication

For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

Dosage

Administer a single, one-time subcutaneous dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated.

Limitations

Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
5 mg/mL meloxicam solution
Dogs
Indication
Indicated in dogs for the control of pain and inflammation associated with osteoarthritis.
Dosage
Administer initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously |IV| or subcutaneously (SQ), fallowed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight either mixed with food or placed directly in the mouth.
Limitations
Do not administer a second dose of meloxicam. Do not follow the single, one-time dose of meloxicam with any other NSAID. Do not administer meloxicam oral suspension following the single, one-time injectable dose of meloxicam.
Cats
Indication
For the control ot postoperative pain and inflammation associated with orthopedic surgery, ovariohystarectomy and castration when administered prior to surgery.
Dosage
Administer a single, one-time subcutaneous dose to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight.
Limitations
Do not administer a second dose of meloxicam. Do not follow the single, one-time dose of meloxicam with any other NSAID. Do not administer meloxicam oral suspension following the single, one-time injectable dose of meloxicam.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
5 mg/mL
<strong>Dogs</strong>
Indication
For the control of pain and inflammation associated with osteoarthritis
Dosage
Meloxicam Solution for Injection should be administered initially as a single dose at 0.09 mg/lb (0.2 mg/kg) body weight intravenously (IV) or subcutaneously (SQ), followed, after 24 hours, by meloxicam oral suspension at the daily dose of 0.045 mg/lb (0.1 mg/kg) body weight, either mixed with food or placed directly in the mouth
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian
<strong>Cats</strong>
Indication
For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery
Dosage
Administer a single, one-time subcutaneous dose of Meloxicam Solution for Injection to cats at a dose of 0.14 mg/lb (0.3 mg/kg) body weight. Use of additional meloxicam or other NSAIDs is contraindicated
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
1.5 mg/mL
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
On the first day of treatment, administer 0.09 mg/lb (0.2 mg/kg). For all treatments after day 1, administer once daily at a dose of 0.045 mg/lb (0.1 mg/ kg).
Limitations
For oral use in dogs only.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of suspension contains 1.5 milligrams (mg) meloxicam.
Label highlights
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs
Dosage
Administer orally as a single dose at 0.09 mg per pound body weight (0.2 milligram per kilogram) on the first day of treatment. For all treatment after day 1, administer 0.045 milligram per pound (0.1 milligram per kilogram) body weight once daily.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 5 milligrams (mg) meloxicam.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer 0.1 mg per kilogram of body weight once daily using the metered dose pump.
Limitations
For oral use in dogs only. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer meloxicam transmucosal oral spray to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Official Documents (FDA)

Direct links to FDA-hosted PDFs and SPL packages (when available).

Documents
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    Dogs: Meloxicam Injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis.

    Cats: For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    To add a claim for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery in cats.
  • Summary
    METACAM (meloxicam) 5 mg/mL Solution for Injection is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    This supplement to NADA 141-213 provides revisions to 21 CFR 520.1350 (1) Amount. To change the format to read “administered initially at 0.09 mg/lb (0.2 mg/kg) body weight only on the first day of treatment. For all treatments after day 1, METACAM Oral Suspension should be administered once daily at a dose of 0.045 mg/lb (0.1 mg/kg).”
  • Summary
    Metacam® Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.
  • Labeling UCM050394.pdf
  • Labeling UCM422143.pdf
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    Dogs: Meloxicam Injection 5 mg/mL Solution for Injection is indicated for the control of pain and inflammation associated with osteoarthritis.
    Cats: For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    Loxicom® (meloxicam) 5 mg/mL Injectable sterile solution is indicated for the control of pain and inflammation associated with osteoarthritis in dogs and for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery in cats.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary

    Dogs: For the control of pain and inflammation associated with osteoarthritis.
    Cats: For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Usage

For the control of pain and inflammation associated with osteoarthritis. For the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy, and castration when administered prior to surgery. For the control of pain and inflammation associated with osteoarthritis in dogs.

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Do not use in cats. Acute renal failure and death have been associated with the use of meloxicam in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral meloxicam to cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Side Effects

No approved side-effect narrative is linked yet.

openFDA reaction signals are available for Dog 56 and Cat 56 (view top reported reactions).

Top Reported Reactions (openFDA)

Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).

Dog
Digestive
Vomiting (623) Diarrhea (365) Loss of appetite (262) Decreased appetite (159) Diarrhea (7) Diarrhea (7) Diarrhea (7) Diarrhea (7) Diarrhea (7) Diarrhea (6) Decreased appetite (3) Decreased appetite (3) Decreased appetite (3) Decreased appetite (3) Vomiting (3) Vomiting (3)
Neurologic
Tiredness (lethargy) (364) Tiredness (lethargy) (6) Tiredness (lethargy) (6) Tiredness (lethargy) (6) Tiredness (lethargy) (6) Tiredness (lethargy) (5) Tiredness (lethargy) (4)
Other
Death by euthanasia (215) Death (181) Not eating (161) Death (9) Death (9) Death (9) Death (9) Death (8) Death (7) Not eating (5) Not eating (5) Not eating (5) Not eating (5) Not eating (5) Not eating (5) Not drinking (4) Not drinking (4) Not drinking (4) Not drinking (4) Abdominal pain (3) Abdominal pain (3) Abdominal pain (3) Abdominal pain (3) Abdominal pain (3) Abdominal pain (3) Abnormal radiograph finding (3) Abnormal radiograph finding (3) Abnormal radiograph finding (3) Abnormal radiograph finding (3) Abnormal radiograph finding (3) Abnormal radiograph finding (3) Elevated serum alkaline phosphatase (3) Elevated serum alkaline phosphatase (3)
Cat
Digestive
Vomiting (140) Loss of appetite (110) Loss of appetite (3) Loss of appetite (3) Loss of appetite (3) Loss of appetite (3) Loss of appetite (3) Loss of appetite (3) Decreased appetite (2) Decreased appetite (2) Decreased appetite (2) Decreased appetite (2) Decreased appetite (2) Decreased appetite (2) Vomiting (2) Vomiting (2) Vomiting (2) Vomiting (2) Vomiting (2) Vomiting (2)
Neurologic
Tiredness (lethargy) (139) Tiredness (lethargy) (3) Tiredness (lethargy) (3) Tiredness (lethargy) (3) Tiredness (lethargy) (3) Tiredness (lethargy) (3) Tiredness (lethargy) (3)
Other
Elevated creatinine (100) Death (89) Not eating (89) Death by euthanasia (77) Elevated blood urea nitrogen (76) Dysphoria (3) Dysphoria (3) Dysphoria (3) Dysphoria (3) Dysphoria (3) Dysphoria (3) Crust (2) Crust (2) Crust (2) Crust (2) Crust (2) Crust (2) Inappropriate defecation (2) Inappropriate defecation (2) Inappropriate defecation (2) Inappropriate defecation (2) Inappropriate defecation (2) Inappropriate defecation (2) Sedation (2) Sedation (2) Sedation (2) Sedation (2) Sedation (2) Sedation (2)

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Boxer (German Boxer), Female, 7 year, 29.484 kilogram • Drug: MSK, Suspension, Oral, Dose: 2.93 Milligram per dose, Frequency: 24 per hour • Reactions: Pacing, Loss of appetite, Abdominal pain, Peritoneal fluid, abnormal NOS, Abnormal radiograph finding… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-054641
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 7.00 Year
  • Weight: 29.484 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Suspension
  • Dose: 2.93 Milligram per dose
  • Frequency: 24 per hour
Reactions Reported:
Pacing Loss of appetite Abdominal pain Peritoneal fluid, abnormal NOS Abnormal radiograph finding Gastric perforation Regurgitation
Outcomes: Ongoing

Cat, Cat (unknown), Female, 4.05 kilogram • Drug: MSK, Solution, Unknown, Dose: 0.16 Milligram per kilogram • Reactions: Hyperglycaemia • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-054116
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Weight: 4.050 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Solution
  • Dose: 0.16 Milligram per kilogram
Reactions Reported:
Hyperglycaemia
Outcomes: Outcome Unknown

Dog, Terrier - Yorkshire, Female, 5 month, 1.814 kilogram • Drug: MSK, Suspension, Oral, Dose: 0.15 Milligram per kilogram • Reactions: Lack of efficacy (virus) - parvovirus, Death, Diarrhea, Not eating, Not drinking • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-056162
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 5.00 Month
  • Weight: 1.814 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Suspension
  • Dose: 0.15 Milligram per kilogram
Reactions Reported:
Lack of efficacy (virus) - parvovirus Death Diarrhea Not eating Not drinking
Outcomes: Died

Dog, Terrier - Yorkshire, Female, 5 month, 1.814 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 0.06 mL per animal • Reactions: Death • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-056175
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 5.00 Month
  • Weight: 1.814 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Injection
  • Dose: 0.06 mL per animal
Reactions Reported:
Death
Outcomes: Died

Cat, Mixed (Cat), Mixed, 11 year • Drug: MSK, Oral, Dose: 0.05 Milligram per kilogram • Reactions: Ulceration NOS, Inappropriate defecation, Crust, Desquamation, Erythema… • Outcome: Recovered/Normal, Died, Outcome Unknown

  • Report ID: AUS-USFDACVM-2025-AU-000005
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Mixed
  • Age: 11.00 Year
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Dose: 0.05 Milligram per kilogram
Reactions Reported:
Ulceration NOS Inappropriate defecation Crust Desquamation Erythema Death Tiredness (lethargy) Loss of appetite
Outcomes: Recovered/Normal, Died, Outcome Unknown

Dog, Retriever - Labrador, Male, 6 year, 48.444 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Hypersensitivity reaction, Localised rash, Overdose, Intentional misuse • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055182
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 6.00 Year
  • Weight: 48.444 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Unassigned
Reactions Reported:
Hypersensitivity reaction Localised rash Overdose Intentional misuse
Outcomes: Ongoing

Dog, Pug, Female, 6 year, 7.8 kilogram • Drug: MSK, Oral, Dose: 0.52 mL per animal, Frequency: 1 per day • Reactions: Diarrhea, Vomiting, Haematochezia • Outcome: Recovered/Normal

  • Report ID: GBR-USFDACVM-2025-GB-000062
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 6.00 Year
  • Weight: 7.800 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Dose: 0.52 mL per animal
  • Frequency: 1 per day
Reactions Reported:
Diarrhea Vomiting Haematochezia
Outcomes: Recovered/Normal

Cat, Domestic Shorthair, Female, 6 year, 4.799 kilogram • Drug: MSK, Suspension, Oral, Dose: 0.09 Milligram per kilogram, Frequency: 1 per day • Reactions: Tiredness (lethargy), Renal failure, Elevated renal parameters, Decreased appetite, Vomiting foam • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-055427
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 6.00 Year
  • Weight: 4.799 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Suspension
  • Dose: 0.09 Milligram per kilogram
  • Frequency: 1 per day
Reactions Reported:
Tiredness (lethargy) Renal failure Elevated renal parameters Decreased appetite Vomiting foam
Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.